Phosphodiesterase-5 Inhibitor Sildenafil Preconditions Adult Cardiac Myocytes against Necrosis and Apoptosis

We investigated the effect of sildenafil in protection against necrosis or apoptosis in cardiomyocytes. Adult mouse ventricular myocytes were treated with sildenafil (1 or 10 μm) for 1 h before 40 min of simulated ischemia (SI). Necrosis was determined by trypan blue exclusion and lactate dehydrogenase release following SI alone or plus 1 or 18 h of reoxygenation (RO). Apoptosis was assessed by terminal deoxynucleotidyl transferase-mediated nick end labeling assay and mitochondrial membrane potential measured using a fluorescent probe 5,5′,6,6′-tetrachloro-1,1′,3,3′-tetraethylbenzimidazolyl-carbocyanine iodide (JC-1). Sildenafil reduced necrosis as indicated by decrease in trypan blue-positive myocytes and leakage of lactate dehydrogenase compared with untreated cells after either SI or SI-RO. The number of terminal deoxynucleotidyl transferase-mediated nick end labeling-positive myocytes or loss of JC-1 fluorescence following SI and 18 h of RO was attenuated in the sildenafil-treated group with concomitant inhibition of caspase 3 activity. An early increase in Bcl-2 to Bax ratio with sildenafil treatment was also observed in myocytes after SI-RO. The increase of Bcl-2 expression by sildenafil was inhibited by nitric-oxide synthase (NOS) inhibitor, l-nitro-amino-methyl-ester. The drug also enhanced mRNA and protein content of inducible NOS (iNOS) and endothelial NOS (eNOS) in the myocytes. Sildenafil-induced protection against necrosis and apoptosis was absent in the myocytes derived from iNOS knock-out mice and was attenuated in eNOS knock-out myocytes. The up-regulation of Bcl-2 expression by sildenafil was also absent in iNOS-deficient myocytes. Reverse transcription-PCR, Western blots, and immunohistochemical assay confirmed the expression of phosphodiesterase-5 in mouse cardiomyocytes. These data provide strong evidence for a direct protective effect of sildenafil against necrosis and apoptosis through NO signaling pathway. The results may have possible therapeutic potential in preventing myocyte cell death following ischemia/reperfusion.

[1]  Anindita Das,et al.  Cardioprotection with phosphodiesterase-5 inhibition--a novel preconditioning strategy. , 2004, Journal of molecular and cellular cardiology.

[2]  R. Kloner,et al.  Therapeutic potential of phosphodiesterase 5 inhibition for cardiovascular disease. , 2003, Circulation.

[3]  Martin R. Wilkins,et al.  Phosphodiesterase Type 5 as a Target for the Treatment of Hypoxia-Induced Pulmonary Hypertension , 2003, Circulation.

[4]  F. Salloum,et al.  Sildenafil Induces Delayed Preconditioning Through Inducible Nitric Oxide Synthase–Dependent Pathway in Mouse Heart , 2003, Circulation research.

[5]  F. Romano,et al.  Inhibition of cyclic GMP hydrolysis with zaprinast reduces basal and cyclic AMP‐elevated L‐type calcium current in guinea‐pig ventricular myocytes , 2003, British journal of pharmacology.

[6]  D Timmann,et al.  Disorders in Timing and Force of Finger Opening in Overarm Throws Made by Cerebellar Subjects , 2002, Annals of the New York Academy of Sciences.

[7]  M. Chopp,et al.  Sildenafil (Viagra) Induces Neurogenesis and Promotes Functional Recovery After Stroke in Rats , 2002, Stroke.

[8]  A. Contestabile,et al.  Nitric oxide regulates cGMP‐dependent cAMP‐responsive element binding protein phosphorylation and Bcl‐2 expression in cerebellar neurons: implication for a survival role of nitric oxide , 2002, Journal of neurochemistry.

[9]  S. Archer,et al.  Oral Sildenafil Is an Effective and Specific Pulmonary Vasodilator in Patients With Pulmonary Arterial Hypertension Comparison With Inhaled Nitric Oxide , 2002 .

[10]  M. I. Tejero-Taldo,et al.  Alpha-adrenergic receptor stimulation produces late preconditioning through inducible nitric oxide synthase in mouse heart. , 2002, Journal of molecular and cellular cardiology.

[11]  G. Sybrecht,et al.  Effect of Inhaled Iloprost Plus Oral Sildenafil in Patients With Primary Pulmonary Hypertension , 2001, Circulation.

[12]  B. Morrissey,et al.  Upregulation of nitric oxide synthase in mice with severe hypoxia-induced pulmonary hypertension , 2001, Respiratory research.

[13]  D. Kass,et al.  Cardiac phosphodiesterase 5 (cGMP‐specific) modulates β‐adrenergic signaling in vivo and is down‐regulated in heart failure , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[14]  E. Marbán,et al.  Mitochondrial ATP-Sensitive Potassium Channels Inhibit Apoptosis Induced by Oxidative Stress in Cardiac Cells , 2001, Circulation research.

[15]  S. Shakir,et al.  Cardiovascular events in users of sildenafil: results from first phase of prescription event monitoring in England , 2001, BMJ : British Medical Journal.

[16]  J. Milbrandt,et al.  Ionizing Radiation Down-regulates p53 Protein in Primary Egr-1−/− Mouse Embryonic Fibroblast Cells Causing Enhanced Resistance to Apoptosis* , 2001, The Journal of Biological Chemistry.

[17]  A. Gibson,et al.  Phosphodiesterase 5 inhibitors and nitrergic transmission-from zaprinast to sildenafil. , 2001, European journal of pharmacology.

[18]  M. Gatzoulis,et al.  Sildenafil in primary pulmonary hypertension. , 2000, The New England journal of medicine.

[19]  S. Homma,et al.  Acute type 5 phosphodiesterase inhibition with sildenafil enhances flow-mediated vasodilation in patients with chronic heart failure. , 2000, Journal of the American College of Cardiology.

[20]  J. Levasseur,et al.  Inducible nitric oxide synthase mediates delayed myocardial protection induced by activation of adenosine A(1) receptors: evidence from gene-knockout mice. , 2000, Circulation.

[21]  A. Magee,et al.  Sildenafil as a selective pulmonary vasodilator in childhood primary pulmonary hypertension , 2000, Heart.

[22]  D. Eaton,et al.  Aldosterone induces ras methylation in A6 epithelia. , 2000, American journal of physiology. Cell physiology.

[23]  G. Gross.  The role of mitochondrial KATP channels in cardioprotection , 2000, Basic Research in Cardiology.

[24]  P. Kang,et al.  Morphological and molecular characterization of adult cardiomyocyte apoptosis during hypoxia and reoxygenation. , 2000, Circulation research.

[25]  C. Franceschi,et al.  Mitochondrial heterogeneity during staurosporine-induced apoptosis in HL60 cells: analysis at the single cell and single organelle level. , 2000, Cytometry.

[26]  A. Mathur,et al.  Evaluation of fluorescent dyes for the detection of mitochondrial membrane potential changes in cultured cardiomyocytes. , 2000, Cardiovascular research.

[27]  E. Marbán,et al.  Activation of mitochondrial ATP-dependent potassium channels by nitric oxide. , 2000, Circulation.

[28]  A. Fokin,et al.  Apoptosis is initiated by myocardial ischemia and executed during reperfusion. , 2000, Journal of molecular and cellular cardiology.

[29]  P. Ping,et al.  The late phase of ischemic preconditioning is abrogated by targeted disruption of the inducible NO synthase gene. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[30]  R. Kitsis,et al.  The mitochondrial apoptotic pathway is activated by serum and glucose deprivation in cardiac myocytes. , 1999, Circulation research.

[31]  M. Hess,et al.  Essential role of inducible nitric oxide synthase in monophosphoryl lipid A-induced late cardioprotection: evidence from pharmacological inhibition and gene knockout mice. , 1999, Circulation.

[32]  E. Lakatta,et al.  Coupling of beta2-adrenoceptor to Gi proteins and its physiological relevance in murine cardiac myocytes. , 1999, Circulation research.

[33]  M. Hess,et al.  Ischemic preconditioning in isolated perfused mouse heart: Reduction in infarct size without improvement of post-ischemic ventricular function , 1998, Molecular and Cellular Biochemistry.

[34]  K. Ferguson,et al.  Isolation and characterization of cDNAs encoding PDE5A, a human cGMP-binding, cGMP-specific 3',5'-cyclic nucleotide phosphodiesterase. , 1998, Gene.

[35]  P. Anversa,et al.  Angiotensin II Induces Apoptosis of Adult Ventricular MyocytesIn Vitro , 1997 .

[36]  H. Shiku,et al.  Characterization of the isoenzymes of cyclic nucleotide phosphodiesterase in human platelets and the effects of E4021. , 1996, Cellular signalling.

[37]  H. Fliss,et al.  Apoptosis in ischemic and reperfused rat myocardium. , 1996, Circulation research.

[38]  J C Gingell,et al.  Sildenafil, a novel effective oral therapy for male erectile dysfunction. , 1996, British journal of urology.

[39]  G. Muirhead,et al.  Sildenafil: an orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction. , 1996, International journal of impotence research.

[40]  R. Kloner,et al.  Reperfusion injury induces apoptosis in rabbit cardiomyocytes. , 1994, The Journal of clinical investigation.

[41]  John Calvin Reed.  Bcl-2 and the regulation of programmed cell death , 1994, The Journal of cell biology.

[42]  S. Baudet,et al.  Sildenafil and vardenafil, types 5 and 6 phosphodiesterase inhibitors, induce caspase-dependent apoptosis of B-chronic lymphocytic leukemia cells. , 2003, Blood.

[43]  W. Bao,et al.  Ischemic preconditioning upregulates inducible nitric oxide synthase in cardiac myocyte. , 2002, Journal of molecular and cellular cardiology.

[44]  N. Maulik,et al.  Cardioprotection with sildenafil, a selective inhibitor of cyclic 3',5'-monophosphate-specific phosphodiesterase 5. , 2002, Drugs under experimental and clinical research.